BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26404792)

  • 1. Multiple reaction monitoring assay based on conventional liquid chromatography and electrospray ionization for simultaneous monitoring of multiple cerebrospinal fluid biomarker candidates for Alzheimer's disease.
    Choi YS; Lee KH
    Arch Pharm Res; 2016 Mar; 39(3):390-7. PubMed ID: 26404792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates.
    Choi YS; Hou S; Choe LH; Lee KH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 930():129-35. PubMed ID: 23735279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-HPLC-MS analysis of phospholipids in cerebrospinal fluid of Alzheimer's disease patients--a pilot study.
    Kosicek M; Kirsch S; Bene R; Trkanjec Z; Titlic M; Bindila L; Peter-Katalinic J; Hecimovic S
    Anal Bioanal Chem; 2010 Dec; 398(7-8):2929-37. PubMed ID: 20953867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel liquid chromatography/tandem mass spectrometry method for the quantification of glycine as biomarker in brain microdialysis and cerebrospinal fluid samples within 5min.
    Voehringer P; Fuertig R; Ferger B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():92-7. PubMed ID: 24121745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
    Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
    Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.
    Hölttä M; Minthon L; Hansson O; Holmén-Larsson J; Pike I; Ward M; Kuhn K; Rüetschi U; Zetterberg H; Blennow K; Gobom J
    J Proteome Res; 2015 Feb; 14(2):654-63. PubMed ID: 25490617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.
    Pannee J; Gobom J; Shaw LM; Korecka M; Chambers EE; Lame M; Jenkins R; Mylott W; Carrillo MC; Zegers I; Zetterberg H; Blennow K; Portelius E
    Alzheimers Dement; 2016 Jan; 12(1):55-9. PubMed ID: 26206625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration.
    Oeckl P; Steinacker P; von Arnim CA; Straub S; Nagl M; Feneberg E; Weishaupt JH; Ludolph AC; Otto M
    J Proteome Res; 2014 Nov; 13(11):4518-25. PubMed ID: 25091646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of peptide adsorption-controlled liquid chromatography-tandem mass spectrometric (PAC-LC-MS/MS) method for simple and simultaneous quantitation of amyloid β 1-38, 1-40, 1-42 and 1-43 peptides in dog cerebrospinal fluid.
    Goda R; Kobayashi N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():137-45. PubMed ID: 22503736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.
    Perrin RJ; Payton JE; Malone JP; Gilmore P; Davis AE; Xiong C; Fagan AM; Townsend RR; Holtzman DM
    PLoS One; 2013; 8(5):e64314. PubMed ID: 23700471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
    Oh JH; Pan S; Zhang J; Gao J
    Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.
    Spellman DS; Wildsmith KR; Honigberg LA; Tuefferd M; Baker D; Raghavan N; Nairn AC; Croteau P; Schirm M; Allard R; Lamontagne J; Chelsky D; Hoffmann S; Potter WZ; ;
    Proteomics Clin Appl; 2015 Aug; 9(7-8):715-31. PubMed ID: 25676562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 96-Well liquid-liquid extraction liquid chromatography-tandem mass spectrometry method for the quantitative determination of ABT-578 in human blood samples.
    Ji QC; Todd Reimer M; El-Shourbagy TA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(1):67-75. PubMed ID: 15113541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease.
    Brinkmalm G; Sjödin S; Simonsen AH; Hasselbalch SG; Zetterberg H; Brinkmalm A; Blennow K
    Proteomics Clin Appl; 2018 Jan; 12(1):. PubMed ID: 29028155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of amyloid beta peptides Aβ(1-38), Aβ(1-40), and Aβ(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry.
    Lame ME; Chambers EE; Blatnik M
    Anal Biochem; 2011 Dec; 419(2):133-9. PubMed ID: 21888888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography-tandem mass spectrometry method for determination of panel of neurotransmitters in cerebrospinal fluid from the rat model for tauopathy.
    Kovac A; Somikova Z; Zilka N; Novak M
    Talanta; 2014 Feb; 119():284-90. PubMed ID: 24401416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a sensitive LC-MS/MS method with electrospray ionization for quantitation of pramipexole in human plasma: application to a clinical pharmacokinetic study.
    Bharathi DV; Hotha KK; Sagar PV; Kumar SS; Naidu A; Mullangi R
    Biomed Chromatogr; 2009 Feb; 23(2):212-8. PubMed ID: 18814193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of cyclosporine, tacrolimus, sirolimus and everolimus by liquid chromatography coupled to electrospray ionization and tandem mass spectrometry: assessment of matrix effects and assay performance.
    Vethe NT; Gjerdalen LC; Bergan S
    Scand J Clin Lab Invest; 2010 Dec; 70(8):583-91. PubMed ID: 21039189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method development and validation for simultaneous quantitation of endogenous hippuric acid and phenylacetylglycine in rat urine using liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    Kamiguchi H; Yamaguchi M; Murabayashi M; Mori I; Horinouchi A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1035():76-83. PubMed ID: 27697729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.